These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry. Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418 [TBL] [Abstract][Full Text] [Related]
6. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry. Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754 [TBL] [Abstract][Full Text] [Related]
7. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945 [TBL] [Abstract][Full Text] [Related]
8. Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH. Zhu N; Swietlik EM; Welch CL; Pauciulo MW; Hagen JJ; Zhou X; Guo Y; Karten J; Pandya D; Tilly T; Lutz KA; Martin JM; Treacy CM; Rosenzweig EB; Krishnan U; Coleman AW; Gonzaga-Jauregui C; Lawrie A; Trembath RC; Wilkins MR; ; ; ; ; Morrell NW; Shen Y; Gräf S; Nichols WC; Chung WK Genome Med; 2021 May; 13(1):80. PubMed ID: 33971972 [TBL] [Abstract][Full Text] [Related]
9. Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chung L; Farber HW; Benza R; Miller DP; Parsons L; Hassoun PM; McGoon M; Nicolls MR; Zamanian RT Chest; 2014 Dec; 146(6):1494-1504. PubMed ID: 24992469 [TBL] [Abstract][Full Text] [Related]
10. Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank). Charoenpong P; Dhillon N; Murnane K; Goeders N; Hall N; Keller C; Bhuiyan MAN; Walter R BMJ Open Respir Res; 2023 Dec; 10(1):. PubMed ID: 38061804 [TBL] [Abstract][Full Text] [Related]
11. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of Patients With Pulmonary Arterial Hypertension in a Pulmonary Hypertension Association-Accredited Comprehensive Care Center: A Contrast in Features When Compared With US National Registry Data. Ingram D; Alamri AK; Penn BA; Mayeux JD; Ma CL; Clapham KR; Abraham AE; Klanderud D; Sadeh B; Beck EM; Hatton ND; Ryan JJ Cureus; 2022 Nov; 14(11):e31764. PubMed ID: 36569732 [TBL] [Abstract][Full Text] [Related]
13. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. Hill KD; Lim DS; Everett AD; Ivy DD; Moore JD Catheter Cardiovasc Interv; 2010 Nov; 76(6):865-73. PubMed ID: 20549685 [TBL] [Abstract][Full Text] [Related]
14. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257 [TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension]. Zhang G; Shang X; Deng X; Zhou H Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1001-5. PubMed ID: 25623345 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Benza RL; Miller DP; Barst RJ; Badesch DB; Frost AE; McGoon MD Chest; 2012 Aug; 142(2):448-456. PubMed ID: 22281797 [TBL] [Abstract][Full Text] [Related]
17. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Brown LM; Chen H; Halpern S; Taichman D; McGoon MD; Farber HW; Frost AE; Liou TG; Turner M; Feldkircher K; Miller DP; Elliott CG Chest; 2011 Jul; 140(1):19-26. PubMed ID: 21393391 [TBL] [Abstract][Full Text] [Related]
18. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A; Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry. Chazova IE; Arkhipova OA; Martynyuk TV Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367 [TBL] [Abstract][Full Text] [Related]
20. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry. Salvador ML; Rodríguez-Padial L; Soto Abánades C; Cruz Utrilla A; Barberá Mir JA; López-Meseguer M; Segovia Cubero J; Samper GJ; Blanco Vich I; Escribano-Subías P; ; J Intern Med; 2022 Jul; 292(1):116-126. PubMed ID: 35184348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]